Literature DB >> 16164485

Valproate: a simple chemical with so much to offer.

G M Peterson1, M Naunton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16164485     DOI： 10.1111/j.1365-2710.2005.00671.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN： 0269-4727            Impact factor:   2.512


× No keyword cloud information.
  28 in total

1.  Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

Authors:  Wendell S Fortson; Shubhalaxmi Kayarthodi; Yasuo Fujimura; Huali Xu; Roland Matthews; William E Grizzle; Veena N Rao; Ganapathy K Bhat; E Shyam P Reddy
Journal:  Int J Oncol       Date:  2011-04-21       Impact factor: 5.650

2.  The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.

Authors:  Abdel Nasser Hosein; Yi Chieh Lim; Bryan Day; Brett Stringer; Stephen Rose; Richard Head; Leah Cosgrove; Peter Sminia; Michael Fay; Jennifer H Martin
Journal:  J Neurooncol       Date:  2015-02-04       Impact factor: 4.130

Review 3.  Valproic Acid: second generation.

Authors:  Meir Bialer; Boris Yagen
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 4.  Pharmacological enhancement of fear reduction: preclinical models.

Authors:  Bronwyn M Graham; Julia M Langton; Rick Richardson
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

Authors:  Paula B M Luís; Jos Ruiter; Lodewijk IJlst; Isabel Tavares de Almeida; Marinus Duran; Ronald J A Wanders; Margarida F B Silva
Journal:  J Inherit Metab Dis       Date:  2013-10-24       Impact factor: 4.982

6.  Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.

Authors:  Ashley L Green; Le Zhan; Aseel Eid; Helmut Zarbl; Grace L Guo; Jason R Richardson
Journal:  Neuropharmacology       Date:  2017-07-22       Impact factor: 5.250

7.  Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.

Authors:  Nikolai D Belyaev; Natalia N Nalivaeva; Natalia Z Makova; Anthony J Turner
Journal:  EMBO Rep       Date:  2008-12-05       Impact factor: 8.807

8.  Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase.

Authors:  Gang Wu; Changlong Nan; Johnathon C Rollo; Xupei Huang; Jie Tian
Journal:  J Biomed Sci       Date:  2010-03-10       Impact factor: 8.410

9.  Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.

Authors:  Ashok Sriram; Herbert E Ward; Anhar Hassan; Sanjay Iyer; Kelly D Foote; Ramon L Rodriguez; Nikolaus R McFarland; Michael S Okun
Journal:  J Neurol       Date:  2012-09-25       Impact factor: 4.849

Review 10.  Valproate-Associated Parkinsonism: A Critical Review of the Literature.

Authors:  Florian Brugger; Kailash P Bhatia; Frank M C Besag
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.